drugset / Trial / NCT05954104

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

NCT05954104

Completed 80 enrolled Egymedicalpedia
RandomizedParallel-groupTriple-blindTreatment

Summary

Alopecia areata (AA) is a common, immune-mediated non scarring alopecia and can be associated with severe psychological consequences . Alopecia Areata affects 2% of the global population. Alopecia Areata prevalence is lower in adults than children, is increasing over time, and significantly differs by region. Its etiology is unknown but it was hypothesized to be an autoimmune disease mediated by T-lymphocytes. It has been suggested that inflammatory T cells induce growth arrest in hair bulbs in the anagen phase of the hair cycle . Cytotoxic T cells secrete tumor necrosis factor, granzymes, and Fas ligand which trigger apoptosis in affected hair follicle and disrupt hair growth

Timeline

Start
2023-07-01
Primary completion
2023-10-01
Completion
2023-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 0.005 % Topical

Indications